CBIO – crescent biopharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CBIO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/22

07:48 am

cbio

Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.

Low Report

Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.

Report

1/22

07:48 am

cbio

Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.

Low Report

Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.

Report

1/21

07:37 am

cbio

Rating for CBIO

Low Report

Rating for CBIO

Report

1/21

07:37 am

cbio

Rating for CBIO

Low Report

Rating for CBIO

Report

1/21

07:17 am

cbio

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Low Report

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Report

1/21

07:17 am

cbio

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Low Report

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.